05/21/2025
8:23 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
6:06 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2025
3:31 PM | Vanda Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2025
3:33 PM | Vanda Pharmaceuticals (Filer)
| Form DEFA14A | |
04/15/2025
4:04 PM | BlackRock Portfolio Management LLC (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
03/17/2025
8:15 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
4:53 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:45 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:46 PM | Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:46 PM | Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:44 PM | Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VNDA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/04/2025
3:45 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:30 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:13 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:38 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:04 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
7:21 PM | Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:43 PM | Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:44 PM | Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:44 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:45 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
3:46 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
12:40 PM | BlackRock, Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/27/2025
7:22 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
4:45 PM | Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
6:07 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/15/2024
7:00 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
4:00 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
7:10 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:47 AM | Vanda Pharmaceuticals (Filer)
| Form 8-A12B/A | |
08/08/2024
6:29 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
6:01 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
3:05 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
4:21 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024
4:24 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:38 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
3:30 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
3:43 PM | Chrousos Phaedra (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
3:49 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
